Obesity
Not recruitingStudy on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight
- Disease:Obesity
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Novo Nordisk A/S
Rare diseases
Investigational molecules
Locations
Back to Germany15 clinical trials in Wangen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical studies focusing on respiratory viral infections in older adults, including trials for RSV and hMPV vaccine development. Additional research addresses bronchiectasis treatment approaches.
Studies aim to evaluate vaccine efficacy and innovative inhalation therapies.
Comprehensive research into Type 2 Diabetes management, including studies of new weekly insulin formulations and novel oral medications. Additional focus on weight management interventions.
Trials evaluate both established and emerging therapeutic approaches.
Dual focus on heart failure prevention and advanced cancer treatments, including studies for non-small cell lung cancer with targeted therapy combinations.
Research emphasizes preventive strategies and personalized treatment options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.